Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | AMLX Amylyx Pharmaceuticals, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $32.41 -4.5% | $15.06 -2.0% |
| StockIQ Score | 57C Moderate Risk: High | 36F Weak Risk: Medium |
| Technical | 55C | 13F |
| Fundamental | 46D+ | 35F |
| Growth | 68B- | 50C- |
| Fair Value | 38F | 38F |
| News | 100A+ | 50C- |
| Quality | 58C | 50C- |
| Risk | 40D | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Amylyx Pharmaceuticals (AMLX) outperforms Ascentage Pharma (AAPG) in nearly every category. AMLX has a stronger investor score (60 vs. 37), a higher technical score (69 vs. 18), and better fundamental and growth scores (46 vs. 35, 68 vs. 50). Both share the same valuation score of 38, but AMLX’s overall rating is "Moderate" compared to AAPG’s "Weak."